Global Spatial Genomics & Transcriptomics Market Size study & Forecast, by Technology (Spatial Transcriptomics, Spatial Genomics) by Product (Instruments, Consumables, Software) by End Use (Translational Research, Academic Customers, Diagnostic Customers, Pharmaceutical Manufacturer), and Regional Analysis, 2022-2029
Global Spatial Genomics & Transcriptomics Market is valued at approximately USD 181.98 million in 2021 and is anticipated to grow with a healthy growth rate of more than 11.10% over the forecast period 2022-2029. Genomic research provides a comprehensive view of the full set of genetic instructions provided by DNA, as opposed to transcriptomics, which studies the patterns of gene expression. The research of all genes and the mRNAs that they are coupled with is known as genomics or transcriptomics, respectively. Spatial genomics holds considerable potential for the diagnosis and treatment of disease due to the availability of quantitative gene expression data and the visualization mapping of DNA and RNA into tissue components. The Spatial Genomics & Transcriptomics Market is expanding because of factors such as Studies on tissue-specific gene expression, embryogenesis, in-vitro fertilization, characterization of non-coding RNAs, stem cell and cancer research, among others, rising prevalence of cancer as well as Advent of the fourth generation of sequencing (in situ sequencing).
The rising prevalence of cancer across the globe is fostering market growth. As Spatial Genomics & Transcriptomics is widely used to perform cancer research activities. The rising prevalence of cancer globally is fostering market growth, the International Agency for Research on Cancer (IARC), the source he estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, along with fresh developments and product releases, the introduction of preventative disease through genomics by several general hospitals and other concerned organizations would contribute to the market's expansion. For instance, a USD 120 million global programme to strengthen equity and enhance outcomes for families affected by genetic illnesses was launched in November 2021 by Illumina and the Genetic Alliance. Moreover, the National Institute of Health declared in March 2022 that it has a dataset of almost 100,000 whole-genome sequencing from widely varied organisms. This demonstrates that government organizations in North America place a significant emphasis on genetics, which will drive the market's expansion over the projection period. However, the gradual adoption of single-cell sequencing and the introduction of novel platforms and technologies for genomics & transcriptomics studies may halt market growth.
The key regions considered for the Global Spatial Genomics & Transcriptomics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the region's increasing disease prevalence and rising clinical research activities in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and rising prevalence of various diseases, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Natera Inc.
10x Genomics
Dovetail Genomics LLC
Illumina, Inc.
S2 Genomics, Inc.
NanoString Technologies, Inc.
Seven Bridges Genomics
Horizon Discovery Group plc
CARTANA AB
READCOOR, INC.
Recent Developments in the Market:
In May 2022, to facilitate spatial biology research using next-generation sequencing, NanoString unveiled a seamless, cloud-based workflow that enhances the spatial data analysis experience for customers using Illumina NextSeq 1000 and NextSeq 2000 sequencing systems as well as the GeoMx Digital Spatial Profiler.
In January 2022, Illumina Inc. and Nashville Biosciences LLC, a fully owned subsidiary of Vanderbilt University Medical Center (VUMC), made a deal over several years to use Illumina's next-generation sequencing (NGS) platforms to create a premier clinical genomic resource and hasten the development of new drugs.
Global Spatial Genomics & Transcriptomics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Product, End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Spatial Transcriptomics
Spatial Genomics
By Product:
Instruments
Consumables
Software
By End Use:
Translational Research
Academic Customers
Diagnostic Customers
Pharmaceutical Manufacturer
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
The rising prevalence of cancer across the globe is fostering market growth. As Spatial Genomics & Transcriptomics is widely used to perform cancer research activities. The rising prevalence of cancer globally is fostering market growth, the International Agency for Research on Cancer (IARC), the source he estimated increase in the worldwide burden of cancer is to 27.5 million new cases by 2040 from 1.9 million new cases in year 2021. Furthermore, along with fresh developments and product releases, the introduction of preventative disease through genomics by several general hospitals and other concerned organizations would contribute to the market's expansion. For instance, a USD 120 million global programme to strengthen equity and enhance outcomes for families affected by genetic illnesses was launched in November 2021 by Illumina and the Genetic Alliance. Moreover, the National Institute of Health declared in March 2022 that it has a dataset of almost 100,000 whole-genome sequencing from widely varied organisms. This demonstrates that government organizations in North America place a significant emphasis on genetics, which will drive the market's expansion over the projection period. However, the gradual adoption of single-cell sequencing and the introduction of novel platforms and technologies for genomics & transcriptomics studies may halt market growth.
The key regions considered for the Global Spatial Genomics & Transcriptomics Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the region's increasing disease prevalence and rising clinical research activities in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and rising prevalence of various diseases, an increase in the number of collaborations for medicine development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.
Major market player included in this report are:
Natera Inc.
10x Genomics
Dovetail Genomics LLC
Illumina, Inc.
S2 Genomics, Inc.
NanoString Technologies, Inc.
Seven Bridges Genomics
Horizon Discovery Group plc
CARTANA AB
READCOOR, INC.
Recent Developments in the Market:
In May 2022, to facilitate spatial biology research using next-generation sequencing, NanoString unveiled a seamless, cloud-based workflow that enhances the spatial data analysis experience for customers using Illumina NextSeq 1000 and NextSeq 2000 sequencing systems as well as the GeoMx Digital Spatial Profiler.
In January 2022, Illumina Inc. and Nashville Biosciences LLC, a fully owned subsidiary of Vanderbilt University Medical Center (VUMC), made a deal over several years to use Illumina's next-generation sequencing (NGS) platforms to create a premier clinical genomic resource and hasten the development of new drugs.
Global Spatial Genomics & Transcriptomics Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Technology, Product, End Use, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Spatial Transcriptomics
Spatial Genomics
By Product:
Instruments
Consumables
Software
By End Use:
Translational Research
Academic Customers
Diagnostic Customers
Pharmaceutical Manufacturer
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Spatial Genomics & Transcriptomics Market, by Region, 2019-2029 (USD Million)
1.2.2. Spatial Genomics & Transcriptomics Market, by Technology, 2019-2029 (USD Million)
1.2.3. Spatial Genomics & Transcriptomics Market, by Product, 2019-2029 (USD Million)
1.2.4. Spatial Genomics & Transcriptomics Market, by End Use, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
3.1. Spatial Genomics & Transcriptomics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Emerging potential of spatial genomic analysis as cancer diagnostic tool
3.1.1.2. Advent of fourth generation of sequencing (in situ sequencing)
3.1.2. Market Challenges
3.1.2.1. High Cost of Spatial Genomics & Transcriptomics
3.1.2.2. Slow implementation of technology
3.1.3. Market Opportunities
3.1.3.1. Gradual adoption of single-cell sequencing
3.1.3.2. Introduction of novel platforms and technologies for genomics & transcriptomics studies
CHAPTER 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Spatial Genomics & Transcriptomics Market by Technology, Performance - Potential Analysis
6.3. Global Spatial Genomics & Transcriptomics Market Estimates & Forecasts by Technology 2019-2029 (USD Million)
6.4. Spatial Genomics & Transcriptomics Market, Sub Segment Analysis
6.4.1. Spatial Transcriptomics
6.4.2. Spatial Genomics
CHAPTER 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Global Spatial Genomics & Transcriptomics Market by Product, Performance - Potential Analysis
7.3. Global Spatial Genomics & Transcriptomics Market Estimates & Forecasts by Product 2019-2029 (USD Million)
7.4. Spatial Genomics & Transcriptomics Market, Sub Segment Analysis
7.4.1. Instruments
7.4.2. Consumables
7.4.3. Software
CHAPTER 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USE
8.1. Market Snapshot
8.2. Global Spatial Genomics & Transcriptomics Market by End Use, Performance - Potential Analysis
8.3. Global Spatial Genomics & Transcriptomics Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
8.4. Spatial Genomics & Transcriptomics Market, Sub Segment Analysis
8.4.1. Translational Research
8.4.2. Academic Customers
8.4.3. Diagnostic Customers
8.4.4. Pharmaceutical Manufacturer
CHAPTER 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, REGIONAL ANALYSIS
9.1. Spatial Genomics & Transcriptomics Market, Regional Market Snapshot
9.2. North America Spatial Genomics & Transcriptomics Market
9.2.1. U.S. Spatial Genomics & Transcriptomics Market
9.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
9.2.1.3. End Use breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Spatial Genomics & Transcriptomics Market
9.3. Europe Spatial Genomics & Transcriptomics Market Snapshot
9.3.1. U.K. Spatial Genomics & Transcriptomics Market
9.3.2. Germany Spatial Genomics & Transcriptomics Market
9.3.3. France Spatial Genomics & Transcriptomics Market
9.3.4. Spain Spatial Genomics & Transcriptomics Market
9.3.5. Italy Spatial Genomics & Transcriptomics Market
9.3.6. Rest of Europe Spatial Genomics & Transcriptomics Market
9.4. Asia-Pacific Spatial Genomics & Transcriptomics Market Snapshot
9.4.1. China Spatial Genomics & Transcriptomics Market
9.4.2. India Spatial Genomics & Transcriptomics Market
9.4.3. Japan Spatial Genomics & Transcriptomics Market
9.4.4. Australia Spatial Genomics & Transcriptomics Market
9.4.5. South Korea Spatial Genomics & Transcriptomics Market
9.4.6. Rest of Asia Pacific Spatial Genomics & Transcriptomics Market
9.5. Latin America Spatial Genomics & Transcriptomics Market Snapshot
9.5.1. Brazil Spatial Genomics & Transcriptomics Market
9.5.2. Mexico Spatial Genomics & Transcriptomics Market
9.5.3. Rest of Latin America Spatial Genomics & Transcriptomics Market
9.6. Rest of The World Spatial Genomics & Transcriptomics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Natera Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. 10x Genomics
10.2.3. Dovetail Genomics LLC
10.2.4. Illumina, Inc.
10.2.5. S2 Genomics, Inc.
10.2.6. NanoString Technologies, Inc.
10.2.7. Seven Bridges Genomics
10.2.8. Horizon Discovery Group plc
10.2.9. CARTANA AB
10.2.10. READCOOR, INC.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Spatial Genomics & Transcriptomics Market, by Region, 2019-2029 (USD Million)
1.2.2. Spatial Genomics & Transcriptomics Market, by Technology, 2019-2029 (USD Million)
1.2.3. Spatial Genomics & Transcriptomics Market, by Product, 2019-2029 (USD Million)
1.2.4. Spatial Genomics & Transcriptomics Market, by End Use, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET DYNAMICS
3.1. Spatial Genomics & Transcriptomics Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Emerging potential of spatial genomic analysis as cancer diagnostic tool
3.1.1.2. Advent of fourth generation of sequencing (in situ sequencing)
3.1.2. Market Challenges
3.1.2.1. High Cost of Spatial Genomics & Transcriptomics
3.1.2.2. Slow implementation of technology
3.1.3. Market Opportunities
3.1.3.1. Gradual adoption of single-cell sequencing
3.1.3.2. Introduction of novel platforms and technologies for genomics & transcriptomics studies
CHAPTER 4. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY TECHNOLOGY
6.1. Market Snapshot
6.2. Global Spatial Genomics & Transcriptomics Market by Technology, Performance - Potential Analysis
6.3. Global Spatial Genomics & Transcriptomics Market Estimates & Forecasts by Technology 2019-2029 (USD Million)
6.4. Spatial Genomics & Transcriptomics Market, Sub Segment Analysis
6.4.1. Spatial Transcriptomics
6.4.2. Spatial Genomics
CHAPTER 7. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY PRODUCT
7.1. Market Snapshot
7.2. Global Spatial Genomics & Transcriptomics Market by Product, Performance - Potential Analysis
7.3. Global Spatial Genomics & Transcriptomics Market Estimates & Forecasts by Product 2019-2029 (USD Million)
7.4. Spatial Genomics & Transcriptomics Market, Sub Segment Analysis
7.4.1. Instruments
7.4.2. Consumables
7.4.3. Software
CHAPTER 8. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, BY END USE
8.1. Market Snapshot
8.2. Global Spatial Genomics & Transcriptomics Market by End Use, Performance - Potential Analysis
8.3. Global Spatial Genomics & Transcriptomics Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
8.4. Spatial Genomics & Transcriptomics Market, Sub Segment Analysis
8.4.1. Translational Research
8.4.2. Academic Customers
8.4.3. Diagnostic Customers
8.4.4. Pharmaceutical Manufacturer
CHAPTER 9. GLOBAL SPATIAL GENOMICS & TRANSCRIPTOMICS MARKET, REGIONAL ANALYSIS
9.1. Spatial Genomics & Transcriptomics Market, Regional Market Snapshot
9.2. North America Spatial Genomics & Transcriptomics Market
9.2.1. U.S. Spatial Genomics & Transcriptomics Market
9.2.1.1. Technology breakdown estimates & forecasts, 2019-2029
9.2.1.2. Product breakdown estimates & forecasts, 2019-2029
9.2.1.3. End Use breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Spatial Genomics & Transcriptomics Market
9.3. Europe Spatial Genomics & Transcriptomics Market Snapshot
9.3.1. U.K. Spatial Genomics & Transcriptomics Market
9.3.2. Germany Spatial Genomics & Transcriptomics Market
9.3.3. France Spatial Genomics & Transcriptomics Market
9.3.4. Spain Spatial Genomics & Transcriptomics Market
9.3.5. Italy Spatial Genomics & Transcriptomics Market
9.3.6. Rest of Europe Spatial Genomics & Transcriptomics Market
9.4. Asia-Pacific Spatial Genomics & Transcriptomics Market Snapshot
9.4.1. China Spatial Genomics & Transcriptomics Market
9.4.2. India Spatial Genomics & Transcriptomics Market
9.4.3. Japan Spatial Genomics & Transcriptomics Market
9.4.4. Australia Spatial Genomics & Transcriptomics Market
9.4.5. South Korea Spatial Genomics & Transcriptomics Market
9.4.6. Rest of Asia Pacific Spatial Genomics & Transcriptomics Market
9.5. Latin America Spatial Genomics & Transcriptomics Market Snapshot
9.5.1. Brazil Spatial Genomics & Transcriptomics Market
9.5.2. Mexico Spatial Genomics & Transcriptomics Market
9.5.3. Rest of Latin America Spatial Genomics & Transcriptomics Market
9.6. Rest of The World Spatial Genomics & Transcriptomics Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Natera Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. 10x Genomics
10.2.3. Dovetail Genomics LLC
10.2.4. Illumina, Inc.
10.2.5. S2 Genomics, Inc.
10.2.6. NanoString Technologies, Inc.
10.2.7. Seven Bridges Genomics
10.2.8. Horizon Discovery Group plc
10.2.9. CARTANA AB
10.2.10. READCOOR, INC.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Spatial Genomics & Transcriptomics Market, report scope
TABLE 2. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by Technology 2019-2029 (USD Million)
TABLE 4. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by Product 2019-2029 (USD Million)
TABLE 5. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by End Use 2019-2029 (USD Million)
TABLE 6. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 17. U.S. Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. U.S. Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 19. Canada Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 20. Canada Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. Canada Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 22. UK Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 23. UK Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. UK Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 25. Germany Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 26. Germany Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. Germany Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 28. France Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 29. France Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. France Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 31. Italy Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 32. Italy Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Italy Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 34. Spain Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 35. Spain Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. Spain Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 37. RoE Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 38. RoE Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. RoE Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 40. China Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 41. China Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. China Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 43. India Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 44. India Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. India Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 46. Japan Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 47. Japan Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. Japan Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 49. South Korea Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 50. South Korea Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. South Korea Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 52. Australia Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 53. Australia Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. Australia Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 55. RoAPAC Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 56. RoAPAC Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. RoAPAC Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 58. Brazil Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 59. Brazil Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Brazil Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 61. Mexico Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 62. Mexico Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. Mexico Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 64. RoLA Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 65. RoLA Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. RoLA Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 67. Row Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 68. Row Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. Row Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Spatial Genomics & Transcriptomics Market
TABLE 71. List of primary sources, used in the study of global Spatial Genomics & Transcriptomics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
TABLE 1. Global Spatial Genomics & Transcriptomics Market, report scope
TABLE 2. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by Region 2019-2029 (USD Million)
TABLE 3. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by Technology 2019-2029 (USD Million)
TABLE 4. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by Product 2019-2029 (USD Million)
TABLE 5. Global Spatial Genomics & Transcriptomics Market estimates & forecasts by End Use 2019-2029 (USD Million)
TABLE 6. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 7. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 8. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 9. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 10. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 11. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 12. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 13. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 14. Global Spatial Genomics & Transcriptomics Market by segment, estimates & forecasts, 2019-2029 (USD Million)
TABLE 15. Global Spatial Genomics & Transcriptomics Market by region, estimates & forecasts, 2019-2029 (USD Million)
TABLE 16. U.S. Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 17. U.S. Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 18. U.S. Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 19. Canada Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 20. Canada Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 21. Canada Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 22. UK Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 23. UK Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 24. UK Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 25. Germany Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 26. Germany Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 27. Germany Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 28. France Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 29. France Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 30. France Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 31. Italy Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 32. Italy Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 33. Italy Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 34. Spain Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 35. Spain Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 36. Spain Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 37. RoE Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 38. RoE Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 39. RoE Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 40. China Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 41. China Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 42. China Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 43. India Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 44. India Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 45. India Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 46. Japan Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 47. Japan Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 48. Japan Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 49. South Korea Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 50. South Korea Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 51. South Korea Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 52. Australia Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 53. Australia Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 54. Australia Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 55. RoAPAC Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 56. RoAPAC Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 57. RoAPAC Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 58. Brazil Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 59. Brazil Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 60. Brazil Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 61. Mexico Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 62. Mexico Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 63. Mexico Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 64. RoLA Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 65. RoLA Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 66. RoLA Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 67. Row Spatial Genomics & Transcriptomics Market estimates & forecasts, 2019-2029 (USD Million)
TABLE 68. Row Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 69. Row Spatial Genomics & Transcriptomics Market estimates & forecasts by segment 2019-2029 (USD Million)
TABLE 70. List of secondary sources, used in the study of global Spatial Genomics & Transcriptomics Market
TABLE 71. List of primary sources, used in the study of global Spatial Genomics & Transcriptomics Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES
FIG 1. Global Spatial Genomics & Transcriptomics Market, research methodology
FIG 2. Global Spatial Genomics & Transcriptomics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Spatial Genomics & Transcriptomics Market, key trends 2021
FIG 5. Global Spatial Genomics & Transcriptomics Market, growth prospects 2022-2029
FIG 6. Global Spatial Genomics & Transcriptomics Market, porters 5 force model
FIG 7. Global Spatial Genomics & Transcriptomics Market, pest analysis
FIG 8. Global Spatial Genomics & Transcriptomics Market, value chain analysis
FIG 9. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Spatial Genomics & Transcriptomics Market, regional snapshot 2019 & 2029
FIG 15. North America Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 16. Europe Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 18. Latin America Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 19. Global Spatial Genomics & Transcriptomics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
FIG 1. Global Spatial Genomics & Transcriptomics Market, research methodology
FIG 2. Global Spatial Genomics & Transcriptomics Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Spatial Genomics & Transcriptomics Market, key trends 2021
FIG 5. Global Spatial Genomics & Transcriptomics Market, growth prospects 2022-2029
FIG 6. Global Spatial Genomics & Transcriptomics Market, porters 5 force model
FIG 7. Global Spatial Genomics & Transcriptomics Market, pest analysis
FIG 8. Global Spatial Genomics & Transcriptomics Market, value chain analysis
FIG 9. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 10. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 11. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 12. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 13. Global Spatial Genomics & Transcriptomics Market by segment, 2019 & 2029 (USD Million)
FIG 14. Global Spatial Genomics & Transcriptomics Market, regional snapshot 2019 & 2029
FIG 15. North America Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 16. Europe Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 17. Asia pacific Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 18. Latin America Spatial Genomics & Transcriptomics Market 2019 & 2029 (USD Million)
FIG 19. Global Spatial Genomics & Transcriptomics Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
